MAGRI, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 5.392
EU - Europa 3.500
AS - Asia 2.914
SA - Sud America 529
AF - Africa 72
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 12.428
Nazione #
US - Stati Uniti d'America 5.245
PL - Polonia 1.313
CN - Cina 994
SG - Singapore 913
IT - Italia 547
UA - Ucraina 500
BR - Brasile 442
DE - Germania 285
VN - Vietnam 272
HK - Hong Kong 254
FI - Finlandia 217
FR - Francia 172
GB - Regno Unito 153
BD - Bangladesh 123
IN - India 104
CA - Canada 91
TR - Turchia 90
RU - Federazione Russa 87
IE - Irlanda 77
ID - Indonesia 34
AR - Argentina 29
MX - Messico 25
ZA - Sudafrica 23
BE - Belgio 22
NL - Olanda 22
SA - Arabia Saudita 21
SE - Svezia 20
CZ - Repubblica Ceca 19
EC - Ecuador 18
JP - Giappone 17
NG - Nigeria 17
AT - Austria 15
AU - Australia 15
IQ - Iraq 15
ES - Italia 14
PK - Pakistan 12
CO - Colombia 11
KE - Kenya 11
VE - Venezuela 9
CL - Cile 7
JM - Giamaica 7
LT - Lituania 7
MA - Marocco 7
CH - Svizzera 6
KR - Corea 6
PY - Paraguay 6
UZ - Uzbekistan 6
EG - Egitto 5
HN - Honduras 5
JO - Giordania 5
KG - Kirghizistan 5
PH - Filippine 5
TT - Trinidad e Tobago 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BG - Bulgaria 4
BH - Bahrain 4
DO - Repubblica Dominicana 4
IL - Israele 4
NP - Nepal 4
PT - Portogallo 4
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
IR - Iran 3
PA - Panama 3
PE - Perù 3
SI - Slovenia 3
UY - Uruguay 3
GR - Grecia 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
CI - Costa d'Avorio 1
CU - Cuba 1
DK - Danimarca 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
PS - Palestinian Territory 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.428
Città #
Warsaw 1.308
Ashburn 509
Singapore 502
Fairfield 463
Woodbridge 342
Jacksonville 336
Ann Arbor 258
Hong Kong 252
San Jose 250
Houston 227
Chandler 226
Beijing 200
Brescia 199
New York 188
Cambridge 182
Seattle 174
Wilmington 162
The Dalles 154
Princeton 148
Helsinki 126
Los Angeles 123
Nanjing 109
Dearborn 91
Dublin 77
Lauterbourg 71
Istanbul 70
Dong Ket 68
Ho Chi Minh City 68
Munich 66
Dallas 63
Des Moines 63
Council Bluffs 54
Nanchang 48
São Paulo 47
Jinan 45
Buffalo 43
Shanghai 43
San Francisco 42
Shenyang 41
Turku 41
Hanoi 36
Hebei 36
Orem 34
Milan 33
Moscow 33
Santa Clara 31
Toronto 30
Chicago 29
Jakarta 26
Redondo Beach 26
Changsha 25
Boardman 23
Jiaxing 23
San Diego 23
Brussels 22
Chennai 22
Rio de Janeiro 21
Montreal 20
London 19
Phoenix 19
Rome 19
Tianjin 19
Brooklyn 18
Hangzhou 17
Washington 17
Zhengzhou 17
Abuja 16
Frankfurt am Main 16
Haikou 15
Atlanta 14
Tokyo 14
Denver 13
Lancaster 13
Naples 13
Nuremberg 13
Bolzano 12
Johannesburg 12
Lanzhou 12
Ningbo 12
Brno 11
Da Nang 11
Guangzhou 11
Mumbai 11
Verona 11
Belo Horizonte 10
Mexico City 10
Stockholm 10
Fuzhou 9
Haiphong 9
Jeddah 9
Manchester 8
Paris 8
Redwood City 8
Salvador 8
San Mateo 8
Brasília 7
Charlotte 7
Düsseldorf 7
Guayaquil 7
Kunming 7
Totale 8.479
Nome #
"GenotypeColour": colour visualisation of SNPs and CNVs 339
SNP array and FISH analysis of a proband with a 22q13.2- 22qter duplication shed light on the molecular origin of the rearrangement 336
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 322
New Copy Number Variations in Schizophrenia 320
ITGB2 mutation combined with deleted ring 21 chromosome in a child with leukocyte adhesion deficiency 311
Compound heterozygosity for a large CNV deletion and a rare missense mutation in the FSTL5 gene of a patient affected by schizophrenia. 303
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 264
Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables 253
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 235
Copy number variants in attention-deficit hyperactive disorder: identification of the 15q13 deletion and its functional role. 231
Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia 226
New biological pathways for major depression: gene expression decomposition in G x E components 214
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 209
Genomic restricted maximum likelihood (GREML) analysis to estimate the heritability of response/resistance in major depressive disorder (MDD) 208
De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay. 207
Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder. 200
Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder 188
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 186
Gene per la neuregulina 1 e schizofrenia: ulteriori evidenze di associazione 186
Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder 180
Analysis of Copy Number Variations in Schizophrenia Italian Patients 173
The Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders 171
Functional study of a novel homozygous mutation in the GAD1 gene, detected in a patient with schizophrenia. 168
Role of allelic variants of FK506-binding protein 51 (FKBP5) gene in the development of anxiety disorders. 168
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 166
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 164
De novo deletion of chromosome 2q24.2 region in a mentally retarded boy with muscular hypotonia 158
Saami and Berbers--an unexpected mitochondrial DNA link 146
Exome sequencing of schizophrenia patients with high level of homozygosity identifies a homozygous novel mutation that reduces the glutamate acid decarboxylase 67 (GAD67) activity 146
RESEARCH OF THE DISEASE-GENE IN A FAMILY AFFECTED BY A TYPE OF CEREBELLAR ATAXIA WITH AN UNKNOWN MOLECULAR DEFECT 145
From surnames to history of Y chromosomes: the Sardinian population as a case test 145
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 142
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 139
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 136
Origin, diffusion and differentiation of Y-chromosome haplogroups E and J: inferences on the Neolithization of Europe and later migratory events in the Mediterranean area 134
The molecular dissection of mtDNA haplogroup H confirms that the Franco-Cantabrian glacial refuge was a major source for the European gene pool 134
Identification and molecular characterization of cryptic chromosomal rearrangements in mental retardation patients. 134
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 133
Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles 133
Phylogeography of Y-chromosome haplogroup I reveals distinct domains of prehistoric gene flow in Europe 132
Long-term effects of HLA A*03:01 genotype on anti-SARS-CoV-2 Spike antibody levels following BNT162b2 vaccine 131
Detection of high level of autozygosity in a group of Italian schizophrenia patients 130
SNP array and FISH analysis of a proband with a 22q13.2- 22qter duplication shades light on the molecular origin of the rearrangement. 128
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 128
New Copy Number Variations in Schizophrenia Italian Patients 124
Application of SNP-arrays, FISH and genotypecolour in molecular diagnosis of mental retardation 124
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 124
Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response 124
Identification and characterization of an Xq26-27 duplication in a male with psycomotor retardation and craniofacial dysmorphisms 123
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 122
Rna editing and modifications in mood disorders 120
Analysis of Citalopram response heterogeneity among STAR*D patients using in-silico methods 119
Ricerca del gene malattia in una famiglia affetta da una forma di atassia cerebellare a difetto molecolare sconosciuto 118
Genome wide study of Italian schizophrenia patients 117
Mitochondrial DNA haplogroups and age at onset of schizophrenia 115
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 114
Identificazione mediante exome sequencing di una variante del gene RBMXL1 in una famiglia affetta da atassia cerebellare pura 112
Genes and MiRNAs in mental retardation patients with cryptic chromosome imbalances detected by SNP-based array analysis. 111
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 109
Genome-wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA-A*03:01 allele 108
Combined DOCK8 and CLEC7A mutations causing immunodeficiency in three brothers with diarrhea, eczema and infections. 108
The effect of childhood trauma on blood transcriptome expression in major depressive disorder 107
Application of SNP-Arrays, FISH and GenotypeColour in Molecular Diagnosis of Mental Retardation 106
Meta-analysis of Genome-Wide Association Studies for Extraversion: Findings from the Genetics of Personality Consortium 106
Y-chromosome and mtDNA polymorphisms in Iraq, a crossroad of the early human dispersal and of post-Neolithic migration 104
Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression 103
Mitochondrial DNA haplogroups do not play a role in the variable phenotypic presentation of the A3243G Mutation 102
GenotypeColour: a coloured way of visualising SNPs and CNVs 99
Assessment of haptoglobin alleles in autism spectrum disorders 97
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 95
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 92
GenotypeColour: un modo colorato di rappresentare SNP e CNV 92
The 49af Haplotype 11 is a new marker of the Eu19 lineage which traces migrations from Northern regions of the Black Sea 91
Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial) 90
Whole blood transcriptome characterization of 3xTg‐AD mouse and its modulation by transcranial direct current stimulation (TDCs) 89
Genome-wide analysis of RNA editing levels in human blood identified interactions with mRNA processing genes and suggested correlations with biological and drug-related variables 84
Transcriptional Profiling of Rat Prefrontal Cortex after Acute Inescapable Footshock Stress 84
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 83
Genome-wide analysis of RNA-editing levels in human blood identifies interactions with mRNA processing genes and suggests correlation with biological and drug-related variables 83
The role of MED22 and its transcriptional interactions with childhood trauma and trauma-focused psychotherapy in patients with major depressive disorder 77
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils 75
Identificazione dei geni di suscettibilità per schizofrenia e disturbo bipolare in un selezionato campione di pazienti italiani 70
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disorders 69
Does pharmacogenetic testing optimise antidepressant effectiveness in major depressive disorder? Data from a double blind randomized controlled trial in a real-world setting 66
Profiling of miR-98-5p, miR-130a-3p, and miR-1246 levels in tissue and liquid biopsies of patients with hepatocellular carcinoma. 66
L'impiego dello Storytelling Thinking® nel trattamento dei pazienti affetti da Disturbo da Gioco d'Azzardo 60
Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics 59
MiR-98-5p, miR-130a-3p, and miR-1246 levels in tissue and liquid biopsies of patients with hepatocellular carcinoma 38
Functional, synaptoproteomic and structural adaptations underlying sex-dependent traumatic stress susceptibility/resilience in the hippocampus 25
Integrated RNA sequencing and in vivo biosensor imaging define the early pathogenic cascade of Duchenne muscular dystrophy 5
Totale 12.711
Categoria #
all - tutte 52.801
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.801


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022686 56 127 31 10 10 25 36 27 42 90 67 165
2022/2023608 89 8 23 61 60 163 3 68 86 11 17 19
2023/2024744 42 21 66 65 40 187 18 17 144 29 9 106
2024/20251.552 13 25 12 210 148 128 108 58 168 126 308 248
2025/20263.519 303 408 221 466 382 257 548 108 210 305 190 121
2026/2027109 109 0 0 0 0 0 0 0 0 0 0 0
Totale 12.711